首页> 外国专利> Of administration of rapamycin analogues with medical equipment for obtaining long-term efficacy and composition

Of administration of rapamycin analogues with medical equipment for obtaining long-term efficacy and composition

机译:雷帕霉素类似物与医疗设备一起用于获得长期疗效和组成的方法

摘要

In comparison with paclitaxel and rapamycin systems, compositions and systems containing low zotarolimus is disclosed the degree of inflammation of a safe, effective, resulting. This is a medical device having a support structure that can support or excipient or pharmaceutically acceptable carrier, it can be a carrier or excipient includes substances or one or more therapeutic agents, and surface Carriers There is a coating on, for example, the coating comprises a therapeutic compound such as pharmaceuticals. The support structure for medical devices, coronary stents used in the vasculature, peripheral stents, catheters, arterio-venous grafts, bypass grafts, and the like drug delivery balloon. These compositions and agents that inhibit anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, antithrombotic agents, cytotoxic agents, chemokine binding or cytokines, cell de-differentiation inhibitors, antilipidemic agents, system, matrix It can metalloprotease inhibitor, used in combination with other agents such as a combination of these and other agents or cytostatic agents.
机译:与紫杉醇和雷帕霉素系统相比,公开了包含低唑达莫司的组合物和系统,其炎症程度是安全,有效的。这是一种具有可以支撑或赋形剂或药学上可接受的载体的支撑结构的医疗器械,它可以是包含物质或一种或多种治疗剂和表面载体的载体或赋形剂,例如在涂层上治疗化合物,例如药物。用于医疗设备的支撑结构,脉管系统中使用的冠状动脉支架,外围支架,导管,动静脉移植物,旁路移植物等类似的药物输送球囊。这些组合物和抑制剂,可抑制抗增殖剂,抗血小板剂,抗炎剂,抗血栓形成剂,细胞毒剂,趋化因子结合或细胞因子,细胞去分化抑制剂,抗血脂药,系统,基质金属蛋白酶可使用与其他药剂联用,例如这些药剂与其他药剂或细胞生长抑制剂的组合。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号